FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the production of antidiabetic agents. A solid dosage form of prolonged action made in the form of tablets with antidiabetic activity containing gliclazide and microencapsulated dry extracts of Galega officinalis, licorice and peppermint, as well as polyethylene glycol 6000, at a certain ratio of components, is proposed.
EFFECT: proposed dosage form is characterized by a prolonged release of gliclazide and pharmacologically active substances contained in dry extracts, provides an increase in the effectiveness and safety of the treatment of diabetes mellitus by controlling the release rate of gliclazide and maintaining its uniform concentration in the blood, as well as smoothing out side effects by plant components of the composition.
1 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIDIABETIC PHARMACEUTICAL COMPOSITION IN THE FORM OF SACHET | 2023 |
|
RU2817200C1 |
EFFERVESCENT PHYTOMINERAL COMPLEX WITH ANTIDIABETIC ACTION | 2015 |
|
RU2625737C2 |
PHARMACEUTICAL COMPOSITION WITH SUSTAINED-RELEASE OF GLICLAZIDE | 2004 |
|
RU2273482C2 |
AGENT FOR PREVENTING AND TREATING INSULIN-INDEPENDENT DIABETES | 2011 |
|
RU2458701C1 |
"MILONA" CURATIVE-SANITATION FOOD BIOLOGICALLY ACTIVE ADDITIVE AND METHOD FOR ITS OBTAINING | 1998 |
|
RU2178660C2 |
COMPOSITION POSSESSING MULTICOMPONENT MECHANISM OF ANTIDIABETIC EFFECT | 2004 |
|
RU2289419C2 |
SOLID UNIT DOSAGE FORM FOR PANCREATIC DIABETES | 2009 |
|
RU2380097C1 |
BIOLOGICALLY ACTIVE DIETARY SUPPLEMENT IN ENCAPSULATED FORM | 2020 |
|
RU2759731C1 |
SOLIDPHASE COMPOSITION OF NATURAL BIOACTIVE INGREDIENTS FOR CORRECTION OF METABOLIC DISTURBANCES IN DIABETES MELLITUS TYPE II | 2017 |
|
RU2661622C1 |
METHOD FOR PRODUCTION OF PLANT-ORIGIN PHARMACEUTICAL AGENT OF SEDATIVE ACTION | 2004 |
|
RU2281111C2 |
Authors
Dates
2023-08-07—Published
2022-06-03—Filed